GlassScriptPhysician profile
Ahmed Ibrahim
NPI 1639481989
$3,488.05
in general payments reported to CMS, 2019-2025
22 companies · $448 in 2025
The $448 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,349 · 2020: $151 · 2021: $343 · 2022: $207 · 2023: $771 · 2024: $218 · 2025: $448.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,438.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,437.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $1,052.60 | 2019 | |
| Biosense Webster, INC. | $274.16 | 2024-2025 | Nuvision Ice Catheter, Carto 3 |
| Medtronic, INC. | $252.03 | 2023 | Micra, Resolute Onyx |
| Boston Scientific Corporation | $167.69 | 2024-2025 | Watchman Flx |
| Inari Medical, INC. | $165.93 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Heartflow, INC. | $159.75 | 2019-2022 | |
| Cvrx, INC. | $153.13 | 2023 | Barostim Neo System |
| Acist Medical Systems, INC. | $147.07 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $144.48 | 2023-2024 | Farxiga, Wainua |
| E.R. Squibb & Sons, L.L.C. | $140.29 | 2019-2023 | Camzyos |
| Janssen Pharmaceuticals, INC | $138.95 | 2020-2022 | |
| Pfizer INC. | $125.00 | 2020 | |
| Philips North America LLC | $100.00 | 2025 | Lm Undivided |
| Novartis Pharmaceuticals Corporation | $97.04 | 2021-2025 | |
| Sanofi-Aventis U.S. LLC | $91.84 | 2019-2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $67.07 | 2025 | Na |
| Amarin Pharma, INC. | $59.55 | 2021 | |
| Merck Sharp & Dohme LLC | $53.60 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $50.09 | 2021 | |
| Amgen INC. | $18.63 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $15.31 | 2021 | |
| Coala Life INC | $13.84 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ahmed Ibrahim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.